InsidersTradesSigma
Total declarations
Company
▲ Purchases (15 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
15
Disclosed sells
2
T+90 hit rate
75%
T+90 mean return
+18.8%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by PORTNOY DAVID, Chief Executive Officer. Director active across 1 company, notably Cryo Cell International INC. Aggregated, 23 filings have been logged. Breakdown: 15 buys · 2 sells. Total volume traded: €114k. Activity tracked since 3 May 2021. The latest transaction was disclosed on 17 November 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations23 total
516 shares@ US$4.900.2% of flowCommon StockSEC:0001209191-22-058194:0
Ideal exit: 14 Aug 2023 (T+270)
3,000 shares@ US$4.791.1% of flowCommon StockSEC:0001209191-22-057065:0
5,000 shares@ US$5.052.0% of flowCommon StockSEC:0001209191-22-056434:0
70,270 shares@ US$3.1417.9% of flowCommon StockSEC:0001209191-22-047883:0
67,816 shares@ US$2.900.57% mcap17.2% of flowCommon StockSEC:0001209191-21-053500:0
67,816 shares@ US$2.9013.6% of flowCommon StockSEC:0001209191-21-053500
158 shares@ US$9.450.1% of flowCommon StockSEC:0001209191-21-048202
Ideal exit: 19 Apr 2022 (T+270)
158 shares@ US$9.450.0043% mcap0.1% of flowCommon StockSEC:0001209191-21-048202:0
Ideal exit: 19 Apr 2022 (T+270)
100 shares@ US$9.2350.1% of flowCommon StockSEC:0001209191-21-047409
Ideal exit: 15 Apr 2022 (T+270)
100 shares@ US$9.2350.0027% mcap0.1% of flowCommon StockSEC:0001209191-21-047409:0
Ideal exit: 15 Apr 2022 (T+270)
946 shares@ US$8.650.023% mcap0.7% of flowCommon StockSEC:0001209191-21-036311:0
Ideal exit: 21 Feb 2022 (T+270)
946 shares@ US$8.650.7% of flowCommon StockSEC:0001209191-21-036311
Ideal exit: 21 Feb 2022 (T+270)
200,000 shares@ US$1.7229.0% of flowCommon StockSEC:0001209191-21-035964
200,000 shares@ US$1.720.97% mcap29.0% of flowCommon StockSEC:0001209191-21-035964:0
1,000 shares@ US$8.460.024% mcap0.7% of flowCommon StockSEC:0001209191-21-035737:0
Ideal exit: 15 Feb 2022 (T+270)
1,000 shares@ US$8.460.7% of flowCommon StockSEC:0001209191-21-035737
Ideal exit: 15 Feb 2022 (T+270)
2,000 shares@ US$8.551.5% of flowCommon StockSEC:0001209191-21-033857
Ideal exit: 7 Feb 2022 (T+270)
2,000 shares@ US$8.550.049% mcap1.5% of flowCommon StockSEC:0001209191-21-033857:0
Ideal exit: 7 Feb 2022 (T+270)
457 shares@ US$8.450.3% of flowCommon StockSEC:0001209191-21-032094
Ideal exit: 4 Feb 2022 (T+270)
457 shares@ US$8.450.011% mcap0.3% of flowCommon StockSEC:0001209191-21-032094:0
Ideal exit: 4 Feb 2022 (T+270)
446 shares@ US$8.500.3% of flowCommon StockSEC:0001209191-21-030364
Ideal exit: 28 Jan 2022 (T+270)
446 shares@ US$8.500.011% mcap0.3% of flowCommon StockSEC:0001209191-21-030364:0
Ideal exit: 28 Jan 2022 (T+270)
118,062 sharesCommon StockSEC:0000899243-16-012550:0
23 of 23 declarations
About PORTNOY DAVID
David Portnoy is an insider at Cryo Cell International Inc.
